WEST HAVEN, Conn.--(BUSINESS WIRE)--Feb. 27, 2006--NanoViricides, Inc. (Pink Sheets:NNVC) announced today that it has been informed of the initial test results of a nanoviricide compound used in its anti-influenza drug, FluCide-I(TM). In preparation for its upcoming trip to Vietnam (the Company had previously announced the signing of a Memorandum of Understanding with the Government of Vietnam for the development of Bird Flu and Rabies drugs), the Company conducted this study to establish certain performance characteristics of its nanoviricide compound.
